US Stock MarketDetailed Quotes

USNA Usana Health Sciences

Watchlist
  • 33.380
  • -1.330-3.83%
Close Dec 20 16:00 ET
  • 33.383
  • +0.003+0.01%
Post 20:01 ET
636.21MMarket Cap11.80P/E (TTM)

Usana Health Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 28, 2024
(Q2)Jun 29, 2024
(Q1)Mar 30, 2024
(FY)Dec 30, 2023
(Q4)Dec 30, 2023
(Q3)Sep 30, 2023
(Q2)Jul 1, 2023
(Q1)Apr 1, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.83%29.53M
-16.34%7.99M
37.79%17.68M
-32.01%70.64M
-35.69%26.02M
-23.66%22.23M
-34.64%9.55M
-34.86%12.83M
-14.29%103.9M
62.36%40.46M
Net income from continuing operations
-6.52%10.61M
-39.67%10.43M
-10.04%16.54M
-8.02%63.79M
31.04%16.77M
-23.99%11.35M
-9.74%17.29M
-18.19%18.38M
-40.47%69.35M
-37.03%12.8M
Operating gains losses
-166.67%-16K
---388K
--405K
-92.91%10K
-166.67%-2K
-62.50%24K
----
----
131.15%141K
-81.25%3K
Depreciation and amortization
7.75%5.56M
10.91%5.7M
-2.68%5.08M
-4.74%20.4M
-7.25%4.87M
-4.90%5.16M
0.27%5.14M
-6.81%5.22M
-3.53%21.41M
-7.22%5.25M
Deferred tax
7.80%871K
13.03%-7.47M
-28.39%2.55M
61.73%-2.75M
29.89%1.47M
154.26%808K
18.19%-8.58M
-3.00%3.56M
-141.85%-7.18M
408.17%1.13M
Change In working capital
970.24%8.59M
44.95%-4.6M
43.17%-11.49M
-3,731.52%-28M
-101.87%-218K
-88.72%803K
-197.33%-8.36M
-32.86%-20.22M
102.33%771K
243.06%11.68M
-Change in inventory
-18.20%692K
-468.86%-2.69M
-2,208.97%-1.8M
-85.10%2.35M
32.20%2.06M
-85.17%846K
-105.56%-472K
-262.50%-78K
207.46%15.8M
125.54%1.56M
-Change in prepaid assets
-67.35%1.02M
-25.84%5.33M
1.86%-5.11M
103.33%110K
-12.14%-5.01M
-26.04%3.13M
695.77%7.19M
-179.09%-5.21M
-41.74%-3.3M
-12.13%-4.46M
-Change in payables and accrued expense
122.43%266K
-72.11%-1.59M
-598.37%-1.72M
83.89%-428K
2,143.02%1.93M
-222.39%-1.19M
40.63%-925K
88.57%-246K
41.91%-2.66M
124.64%86K
-Change in other current liabilities
432.86%6.61M
60.02%-5.66M
80.50%-2.87M
-231.28%-30.03M
-94.47%802K
47.50%-1.99M
-65.83%-14.16M
-30.60%-14.69M
20.86%-9.07M
543.00%14.51M
Cash from discontinued investing activities
Operating cash flow
32.83%29.53M
-16.34%7.99M
37.79%17.68M
-32.01%70.64M
-35.69%26.02M
-23.66%22.23M
-34.64%9.55M
-34.86%12.83M
-14.29%103.9M
62.36%40.46M
Investing cash flow
Cash flow from continuing investing activities
-60.80%-2.34M
-963.69%-1.55M
-20.43%-4.07M
3.19%-11.98M
-123.10%-7.32M
59.37%-1.45M
104.81%179K
-89.14%-3.38M
12.81%-12.37M
-4.09%-3.28M
Net PPE purchase and sale
-60.80%-2.34M
25.72%-2.67M
-51.78%-3.2M
-39.31%-14.48M
-123.10%-7.32M
59.37%-1.45M
-105.96%-3.6M
-17.97%-2.11M
18.47%-10.39M
-4.09%-3.28M
Net business purchase and sale
----
----
----
--0
----
----
----
----
---6.53M
--0
Net investment purchase and sale
--0
-70.20%1.13M
31.55%-870K
-45.03%2.5M
--0
--0
-17.12%3.78M
---1.27M
392.93%4.56M
--0
Cash from discontinued investing activities
Investing cash flow
-60.80%-2.34M
-963.69%-1.55M
-20.43%-4.07M
3.19%-11.98M
-123.10%-7.32M
59.37%-1.45M
104.81%179K
-89.14%-3.38M
12.81%-12.37M
-4.09%-3.28M
Financing cash flow
Cash flow from continuing financing activities
99.33%-78K
-2,360.00%-1.35M
-273.43%-11.95M
52.68%-14.24M
538.67%658K
-26,356.82%-11.64M
99.47%-55K
83.67%-3.2M
83.41%-30.09M
99.54%-150K
Net issuance payments of debt
--1K
---1.32M
--537K
--792K
--792K
--0
--0
--0
--0
--0
Net common stock issuance
--0
--0
---9.44M
54.30%-11.6M
--0
---11.6M
--0
--0
85.73%-25.38M
--0
Net other financing activities
-88.10%-79K
43.64%-31K
5.00%-3.04M
27.11%-3.43M
10.67%-134K
4.55%-42K
81.73%-55K
24.03%-3.2M
-31.64%-4.71M
71.91%-150K
Cash from discontinued financing activities
Financing cash flow
99.33%-78K
-2,360.00%-1.35M
-273.43%-11.95M
52.68%-14.24M
538.67%658K
-26,356.82%-11.64M
99.47%-55K
83.67%-3.2M
83.41%-30.09M
99.54%-150K
Net cash flow
Beginning cash position
10.64%335.18M
10.97%331.11M
14.39%333.25M
19.56%291.32M
23.75%309.82M
29.45%302.94M
23.51%298.37M
19.56%291.32M
-22.88%243.65M
-0.61%250.36M
Current changes in cash
196.73%27.12M
-47.38%5.09M
-73.32%1.67M
-27.69%44.43M
-47.72%19.36M
-64.16%9.14M
1,542.61%9.68M
472.82%6.26M
182.62%61.44M
446.86%37.03M
Effect of exchange rate changes
341.38%5.45M
79.96%-1.02M
-582.15%-3.81M
81.83%-2.5M
3.54%4.06M
75.38%-2.26M
37.28%-5.1M
296.03%790K
-759.82%-13.78M
60.93%3.93M
End cash Position
18.69%367.74M
10.64%335.18M
10.97%331.11M
14.39%333.25M
14.39%333.25M
23.75%309.82M
29.45%302.94M
23.51%298.37M
19.56%291.32M
19.56%291.32M
Free cash flow
30.58%27.14M
-10.48%5.32M
35.02%14.48M
-39.95%56.15M
-49.70%18.7M
-18.65%20.78M
-53.82%5.94M
-40.12%10.73M
-13.79%93.5M
70.78%37.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 28, 2024(Q2)Jun 29, 2024(Q1)Mar 30, 2024(FY)Dec 30, 2023(Q4)Dec 30, 2023(Q3)Sep 30, 2023(Q2)Jul 1, 2023(Q1)Apr 1, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.83%29.53M-16.34%7.99M37.79%17.68M-32.01%70.64M-35.69%26.02M-23.66%22.23M-34.64%9.55M-34.86%12.83M-14.29%103.9M62.36%40.46M
Net income from continuing operations -6.52%10.61M-39.67%10.43M-10.04%16.54M-8.02%63.79M31.04%16.77M-23.99%11.35M-9.74%17.29M-18.19%18.38M-40.47%69.35M-37.03%12.8M
Operating gains losses -166.67%-16K---388K--405K-92.91%10K-166.67%-2K-62.50%24K--------131.15%141K-81.25%3K
Depreciation and amortization 7.75%5.56M10.91%5.7M-2.68%5.08M-4.74%20.4M-7.25%4.87M-4.90%5.16M0.27%5.14M-6.81%5.22M-3.53%21.41M-7.22%5.25M
Deferred tax 7.80%871K13.03%-7.47M-28.39%2.55M61.73%-2.75M29.89%1.47M154.26%808K18.19%-8.58M-3.00%3.56M-141.85%-7.18M408.17%1.13M
Change In working capital 970.24%8.59M44.95%-4.6M43.17%-11.49M-3,731.52%-28M-101.87%-218K-88.72%803K-197.33%-8.36M-32.86%-20.22M102.33%771K243.06%11.68M
-Change in inventory -18.20%692K-468.86%-2.69M-2,208.97%-1.8M-85.10%2.35M32.20%2.06M-85.17%846K-105.56%-472K-262.50%-78K207.46%15.8M125.54%1.56M
-Change in prepaid assets -67.35%1.02M-25.84%5.33M1.86%-5.11M103.33%110K-12.14%-5.01M-26.04%3.13M695.77%7.19M-179.09%-5.21M-41.74%-3.3M-12.13%-4.46M
-Change in payables and accrued expense 122.43%266K-72.11%-1.59M-598.37%-1.72M83.89%-428K2,143.02%1.93M-222.39%-1.19M40.63%-925K88.57%-246K41.91%-2.66M124.64%86K
-Change in other current liabilities 432.86%6.61M60.02%-5.66M80.50%-2.87M-231.28%-30.03M-94.47%802K47.50%-1.99M-65.83%-14.16M-30.60%-14.69M20.86%-9.07M543.00%14.51M
Cash from discontinued investing activities
Operating cash flow 32.83%29.53M-16.34%7.99M37.79%17.68M-32.01%70.64M-35.69%26.02M-23.66%22.23M-34.64%9.55M-34.86%12.83M-14.29%103.9M62.36%40.46M
Investing cash flow
Cash flow from continuing investing activities -60.80%-2.34M-963.69%-1.55M-20.43%-4.07M3.19%-11.98M-123.10%-7.32M59.37%-1.45M104.81%179K-89.14%-3.38M12.81%-12.37M-4.09%-3.28M
Net PPE purchase and sale -60.80%-2.34M25.72%-2.67M-51.78%-3.2M-39.31%-14.48M-123.10%-7.32M59.37%-1.45M-105.96%-3.6M-17.97%-2.11M18.47%-10.39M-4.09%-3.28M
Net business purchase and sale --------------0-------------------6.53M--0
Net investment purchase and sale --0-70.20%1.13M31.55%-870K-45.03%2.5M--0--0-17.12%3.78M---1.27M392.93%4.56M--0
Cash from discontinued investing activities
Investing cash flow -60.80%-2.34M-963.69%-1.55M-20.43%-4.07M3.19%-11.98M-123.10%-7.32M59.37%-1.45M104.81%179K-89.14%-3.38M12.81%-12.37M-4.09%-3.28M
Financing cash flow
Cash flow from continuing financing activities 99.33%-78K-2,360.00%-1.35M-273.43%-11.95M52.68%-14.24M538.67%658K-26,356.82%-11.64M99.47%-55K83.67%-3.2M83.41%-30.09M99.54%-150K
Net issuance payments of debt --1K---1.32M--537K--792K--792K--0--0--0--0--0
Net common stock issuance --0--0---9.44M54.30%-11.6M--0---11.6M--0--085.73%-25.38M--0
Net other financing activities -88.10%-79K43.64%-31K5.00%-3.04M27.11%-3.43M10.67%-134K4.55%-42K81.73%-55K24.03%-3.2M-31.64%-4.71M71.91%-150K
Cash from discontinued financing activities
Financing cash flow 99.33%-78K-2,360.00%-1.35M-273.43%-11.95M52.68%-14.24M538.67%658K-26,356.82%-11.64M99.47%-55K83.67%-3.2M83.41%-30.09M99.54%-150K
Net cash flow
Beginning cash position 10.64%335.18M10.97%331.11M14.39%333.25M19.56%291.32M23.75%309.82M29.45%302.94M23.51%298.37M19.56%291.32M-22.88%243.65M-0.61%250.36M
Current changes in cash 196.73%27.12M-47.38%5.09M-73.32%1.67M-27.69%44.43M-47.72%19.36M-64.16%9.14M1,542.61%9.68M472.82%6.26M182.62%61.44M446.86%37.03M
Effect of exchange rate changes 341.38%5.45M79.96%-1.02M-582.15%-3.81M81.83%-2.5M3.54%4.06M75.38%-2.26M37.28%-5.1M296.03%790K-759.82%-13.78M60.93%3.93M
End cash Position 18.69%367.74M10.64%335.18M10.97%331.11M14.39%333.25M14.39%333.25M23.75%309.82M29.45%302.94M23.51%298.37M19.56%291.32M19.56%291.32M
Free cash flow 30.58%27.14M-10.48%5.32M35.02%14.48M-39.95%56.15M-49.70%18.7M-18.65%20.78M-53.82%5.94M-40.12%10.73M-13.79%93.5M70.78%37.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.